Fresenius Medical Care AG (NYSE:FMS)  posted a healthy quarter with growth in sales and earnings driven by a 26 percent bump in international sales.

"We are particularly pleased with the success of our international region, given a persistently challenging business environment with the current debt crisis worldwide and the successful expansion of our clinic network in Asia-Pacific and Europe," CEO Dr. Ben Lipps said in prepared remarks.